• Search Funds
  • Model Portfolios
  • Provider
  • Sector
  • Manager

Search by provider name

Search by sector name

Search by manager name

Search by Risk Level

AXA Framlington Health Fund Z Acc

  • Fund Info & charges
  • Performance
  • Fund breakdown
  • Dividend History
Fund ProviderAXA Investment Managers UK Ltd
Fund SummaryThe aim of the Fund is to generate capital growth through investment in healthcare and medical services and product companies worldwide.
Fund codeFMHEA
ManagersDani Saurymper, Linden Thomson
Manager Tenure5 years
Morningstar CategorySector Equity Healthcare
IMA SectorSpecialist
Fund Size£536 million
Fund TypeOEIC
Management StyleActive
Ongoing Charge Figure (OCF)0.82%
Cavendish ongoing charge0.05%
FundsNetwork Service Fee0.20%
Minimum Initial Investment£25
Minimum Top Up£25
Minimum Monthly Investment£25
Sell Price£3.2850
Buy Price£3.2850
Price Change-0.3337%
Price Date29th September 2020
Dividend FrequencySemi-Annually
ISA EligibleYes
SIPP EligibleYes
Inception Date29th May 2013
Fund StatusOPEN
Dani Saurymper joined AXA IM in April 2015 as Fund Manager for the AXA Framlington Health Fund. He joined from Barclays Capital where he was a senior equity research analyst covering European healthcare.

3-year Mean Monthly Return: 0.859%

Annual Returns2019201820172016201520142013201220112010
Fund Performance+16.37%+7.83%+2.71%+14.10%+3.78%+34.57%+19.20%+23.30%+7.36%+21.18%
Benchmark Performance
(Sector Equity Healthcare)
Time PeriodCumulativeBenchmark Performance
(Sector Equity Healthcare)
Fund Compared to Benchmark
1 day-0.33%+13.00%-13.34%
1 week-0.15%+2.62%-2.78%
1 month1.86%+0.71%+1.15%
3 months3.40%+23.27%-19.87%
6 months25.91%+19.80%+6.11%
1 year17.49%+10.78%+6.71%
3 years11.32%+12.07%-0.75%
5 years11.58%+13.57%-1.99%
10 years14.69%+10.39%+4.30%
Since inception12.63%Currently unavailableCurrently unavailable

Top 10 shares for this fund

Share NameCountryValue
UnitedHealth Group IncUSA5.70%
Merck & Co IncUSA5.59%
Roche Holding AG Dividend Right Cert.CHE4.79%
AstraZeneca PLCGBR4.27%
Horizon Therapeutics PLCUSA3.85%
Thermo Fisher Scientific IncUSA3.61%
Pfizer IncUSA2.93%
Takeda Pharmaceutical Co LtdJPN2.86%
Medtronic PLCUSA2.73%
CVS Health CorpUSA2.53%
Dividend DatePer share amountReinvestment Price
1st November 20190.0063£2.7390
1st November 20180.0058£2.6270
1st November 20170.0090£2.3500
1st November 20160.0081£2.2610
2nd November 20150.0040£1.9880
3rd November 20140.0030£1.7830